Viability of Equine Chondrocytes After Exposure to Mepivacaine and Ropivacaine In Vitro
-
Add time:07/29/2019 Source:sciencedirect.com
Chondrocyte health is altered when exposed to local anesthetics, raising concerns as to the long-term effects of local anesthetics intra-articularly for diagnosis and analgesia. To investigate the drug with the lowest toxic potential, the effect of ropivacaine and mepivacaine on chondrocytes was evaluated. Articular cartilage from normal metacarpophalangeal joints of five equine cadaver specimens was used to establish chondrocyte cultures. Following seven days, chondrocytes were exposed to standard culture medium (DMEM), ropivacaine 7.5 mg/ml (ROP7.5), ropivacaine 10 mg/ml (ROP10), mepivacaine 20 mg/ml (MEP20), mepivacaine 30 mg/ml (MEP 30), and 0.9% saline solution (SAL). Chondrocyte viability was evaluated by trypan blue exclusion, MTT, and flow cytometry via cellular staining with propidium iodide. No differences were observed between treatments following trypan blue exclusion assay. A difference was observed between DMEM and all other treatment groups (P < .0001) with a significant viability drop using the MTT assay. Mepivacaine 20 mg/ml and MEP30 exposure between showed greatest decrease in cellular viability compared to SAL, ROP7.5, and ROP10 (P < .0001). Cellular viability decreased as measured by flow cytometry in all groups compared to DMEM and ROP7.5 (P < .02). Interestingly, the trypan blue, MTT, and flow cytometry assays yielded different results. Although there was no difference using trypan blue, MTT demonstrated that ropivacaine-treated cells had lower viability than DMEM, and cytometry found that ROP7.5 did not differ from DMEM. Results in vitro suggest that short-term exposure to ropivacaine may result in less chondrotoxicity than mepivacaine. In vivo studies are warranted investigating long-term effects of local anesthetics on equine articular cartilage.
We also recommend Trading Suppliers and Manufacturers of Ropivacaine hydrochloride (cas 132112-35-7). Pls Click Website Link as below: cas 132112-35-7 suppliers
Prev:The effects of Ropivacaine hydrochloride (cas 132112-35-7) on the expression of CaMK II mRNA in the dorsal root ganglion neurons
Next:Ropivacaine regulates the expression and function of heme oxygenase-1) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- In vivo evaluation of post-operative pain reduction on rat model after implantation of intraperitoneal PET meshes functionalised with cyclodextrins and loaded with ropivacaine08/06/2019
- Effective concentration of levobupivacaine and ropivacaine in 80% of patients receiving epidural analgesia (EC80) in the first stage of labour: A study using the Continual Reassessment Method08/05/2019
- Ropivacaine/Fentanyl vs. Bupivacaine/Fentanyl for Pain Control in Children after Thoracic Surgery: A Randomized Study08/04/2019
- Assessment of the analgesic potency of ropivacaine 0.2% versus ropivacaine 0.5% in transversus abdominis plane block after cesarean delivery08/03/2019
- Ropivacaine: a new local anaesthetic agent in maxillofacial surgery08/02/2019
- Immediate postoperative pain control with ropivacaine following laparoscopic-assisted vaginal hysterectomy: A randomized double-blind pilot study08/01/2019
- Analgesic, hemodynamic and respiratory effects of caudal epidurally administered Ropivacaine hydrochloride (cas 132112-35-7) in mares07/31/2019
- Ropivacaine regulates the expression and function of heme oxygenase-107/30/2019
- The effects of Ropivacaine hydrochloride (cas 132112-35-7) on the expression of CaMK II mRNA in the dorsal root ganglion neurons07/28/2019
-
Health and Chemical more >


